What does the future of aging and longevity hold? Can science hack the human lifespan? Even if we can, SHOULD we…?

People aren’t dying as early or as easily as they used to. Innovations in modern medicine, health, and hygiene helped us extend our lives by decades, but what comes next? Would you rather live to be a healthy and hearty 90 or live to be 150 but wither away for the last 60 years? We’ll talk about it in this episode of Far Out.

Far Out explores the future of science, technology, and culture and how these changes may affect humanity and life on Earth. The series is hosted by Swapna Krishna, a science journalist, podcaster, and sci-fi writer covering everything from NASA to Marvel, and produced for PBS by PBS North Carolina, the team behind the award-winning PBS series Overview.

#FutureOfAging #Lifespan #FarOut.

Hevolution Foundation, a non-profit organisation that provides grants and early-stage investments to incentivise research and entrepreneurship in healthspan science, and the American Federation for Aging Research (AFAR) have today announced an international research grant programme to enable early-career investigators to conduct research into healthspan-expanding therapeutics and treatments.

Longevity. Technology: Founded in the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, the Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development and increase accessibility to therapeutics that extend healthspan.

A non-profit organisation headquartered in Riyadh, with an annual budget of up to $1 billion, Hevolution Foundation plans to open hubs in North America and other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer.

Scientists study the immortal jellyfish to learn about its DNA reproduction, life cycle and telomeres. New research reveals its special genes.

T. dohrnii is the only species that is biologically immortal, and now scientists have peered into its DNA to find out what lets it live forever.

Scientists say medication also used after undergoing an organ transplant is capable of extending life with only brief use

COLOGNE, Germany — A drug that patients normally take during cancer therapy may have the power to increase the human lifespan, a new study reveals. Researchers in Germany say rapamycin can cause side-effects when patients take it as a lifelong anti-aging treatment. However, their new report finds even brief usage can have a dramatic impact on longevity while cutting down on side-effects.

Summary: Brief exposure to Rapamycin, a promising anti-aging drug that has positive effects on health and lifespan, has the same effect as long-term exposure to the drug in animal models. The findings pave the way for testing the effects of short-term rapamycin exposure on the lifespan of humans.

Source: Max Planck Institute.

Imagine you could take a medicine that prevents the decline that come with age and keeps you healthy. Scientists are trying to find a drug that has these effects.